Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Clinical trial NCT01780506 · COMPLETED
Trial details
- NCT number
- NCT01780506
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-26
- Primary completion
- 2014-08-26
- Enrollment
- 872
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.